NARS-3′ is a selective reversible inhibitor of xanthine oxidase, exhibiting an IC50 of 21.01 μM. This compound effectively competes with substrates to diminish uric acid production, demonstrating potential in mitigating renal damage in hyperuricemia models. NARS-3′ is suitable for research applications focused on hyperuricemia and related metabolic disorders.
NARS-3′ is a selective reversible inhibitor of xanthine oxidase, exhibiting an IC50 of 21.01 μM. This compound effectively competes with substrates to diminish uric acid production, demonstrating potential in mitigating renal damage in hyperuricemia models. NARS-3′ is suitable for research applications focused on hyperuricemia and related metabolic disorders.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: